ACOG/LinkedIn
Oct 15, 2025, 09:08
ACOG Publishes Clinical Update on Postpartum Zuranolone Therapy
American College of Obstetricians and Gynecologists (ACOG) shared a post on LinkedIn:
“ACOG’s latest Clinical Practice Update makes finding the guidance you need on treating depression with zuranolone during the postpartum period easier to find, understand, and put into practice, with clear recommendations, implementation considerations, and more. The guidance also answers questions about clinical scenarios that may arise when considering zuranolone and includes newly available data about concentrations of zuranolone in human milk. Read the guidance.”
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Nov 5, 2025, 13:34Nibhash Kumar: When Embryos Stop Growing and the Hidden Reasons Behind Early Developmental Arrest
-
Nov 5, 2025, 13:29Ahsan Saeed: DNA From Three Parents Just Stopped a Life-Threatening Disorder Before Birth!
-
Nov 5, 2025, 13:24New Weighted Classification Criteria Refine Antiphospholipid Syndrome Research – Hæmatologi DK
-
Nov 4, 2025, 15:34Optimal Endometrial Thickness Up to 12 mm Boosts Live Birth Rates in IVF – Fertility Plus
-
Nov 4, 2025, 15:20hCG and GnRH Analogue Trigger Show Similar Outcomes in IVF Cycles – Fertility Plus
-
Nov 4, 2025, 15:08Nyakaishiki Mercy: Pregnant Women Shouldn’t Get Leave From Work
-
Nov 4, 2025, 14:55Fewer Preeclampsia Cases Reported With Closed-Loop Insulin Use in Type 1 Diabetic Pregnancies – Medical Xpress
-
Nov 4, 2025, 14:42Meghna Rao: Exploring the Role of the Gut Microbiome in Women’s Reproductive Health
-
Nov 4, 2025, 14:23Fatemeh Zarimeidani: Advancing Care for PCOS-Related Infertility